In non-small cell lung cancer cells, TGF-β signaling upregulated the expression of MRTF (through a RhoA/ROCK non-canonical mechanism), which interacted with NF-κB/p65 to promote PD-L1 expression through transcription [122]. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.